Implican Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$10.9M
- Investors
-
6
Implican General Information
Description
Developer of an anastomotic device designed to reduce anastomotic leakage. The company's device is based on compression and fixation of the bowel wall with the use of two rings, and using this compression, the wound will heal by primary intent, resulting in reduced anastomotic leakage, enabling surgeons to reduce complications during abdominal surgery.
Contact Information
Website
www.implican.nlCorporate Office
- L.J.Zielstraweg 2
- 9713 GX Groningen
- Netherlands
Corporate Office
- L.J.Zielstraweg 2
- 9713 GX Groningen
- Netherlands
Implican Timeline
Implican Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series A) | 10-Apr-2025 | $10.9M | Completed | Generating Revenue | ||
| 7. Grant | 01-May-2024 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Jan-2024 | Completed | Startup | |||
| 5. Seed Round | Cancelled | Startup | ||||
| 4. Grant | 01-Nov-2023 | Completed | Startup | |||
| 3. Seed Round | 01-Nov-2022 | Completed | Startup | |||
| 2. Grant | 01-Jan-2021 | $48.7K | Completed | Startup | ||
| 1. Grant | 01-Jan-2020 | $22.2K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Implican Patents
Implican Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3233316-A1 | Device for performing anastomosis | Pending | 28-Sep-2021 | ||
| EP-4408306-A1 | Device for performing anastomosis | Pending | 28-Sep-2021 | ||
| US-20250049438-A1 | Device for performing anastomosis | Pending | 28-Sep-2021 | ||
| WO-2023055232-A1 | Device for performing anastomosis | Inactive | 28-Sep-2021 | ||
| CA-3045605-A1 | Instrument for performing anastomosis | Pending | 02-Dec-2016 | A61B17/1114 |
Implican Signals
Implican Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| EUREKA Eurostars | Government | |||
| Medlim | Accelerator/Incubator | |||
| Hanzepoort | Venture Capital | Minority | ||
| Nextgen Ventures | Venture Capital | Minority | ||
| Noordelijke Ontwikkelings Maatschappij | PE/Buyout | Minority |
Implican FAQs
-
When was Implican founded?
Implican was founded in 2016.
-
Where is Implican headquartered?
Implican is headquartered in Groningen, Netherlands.
-
What is the size of Implican?
Implican has 5 total employees.
-
What industry is Implican in?
Implican’s primary industry is Surgical Devices.
-
Is Implican a private or public company?
Implican is a Private company.
-
What is Implican’s current revenue?
The current revenue for Implican is .
-
How much funding has Implican raised over time?
Implican has raised $11.9M.
-
Who are Implican’s investors?
EUREKA Eurostars, Medlim, Hanzepoort, Nextgen Ventures, and Noordelijke Ontwikkelings Maatschappij are 5 of 6 investors who have invested in Implican.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process